RC

RA CAPITAL MANAGEMENT, L.P.

DELAYED 1 MONTH

10% Owner; Director; Director, 10% Owner

Acrivon Therapeutics, Inc.
Acumen Pharmaceuticals, Inc.
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Hemab Therapeutics Holdings, Inc.
Inhibikase Therapeutics, Inc.
Nkarta, Inc.

Filings

19

Companies

11

Latest

Jul 29, 2026

Transactions

Signal

Ticker / Company

Insider

Transaction

Value

Filed

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$247.7K

24,944 sh

Jul 31 9:13 PM

Jul 31, 2026

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$208.0K

20,824 sh

Jul 31 9:13 PM

Jul 29, 2026

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$596.4K

59,880 sh

Jul 24 1:22 AM

Jul 23, 2026

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$835.4K

84,124 sh

Jul 24 1:22 AM

Jul 22, 2026

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$1.2M

120,582 sh

Jul 24 1:22 AM

Jul 21, 2026

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$58.3K

6,522 sh

Jul 24 1:21 AM

Jul 13, 2026 · 4/A

—

Werewolf Therapeutics, Inc.

Sale

$99.8K

262,503 sh

Jun 12 12:13 AM

Jun 11, 2026

—

Werewolf Therapeutics, Inc.

Sale

$17.0K

45,923 sh

Jun 12 12:13 AM

Jun 10, 2026

—

Werewolf Therapeutics, Inc.

Sale

$136.8K

369,800 sh

Jun 12 12:13 AM

Jun 9, 2026

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$4.3M

548,580 sh

Jun 11 11:36 PM

Jun 11, 2026

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$721

103 sh

Jun 11 11:36 PM

Jun 10, 2026

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$3.3M

479,039 sh

Jun 11 11:36 PM

Jun 9, 2026

—

Hemab Therapeutics Holdings, Inc.

Purchase

$24.8K

996 sh

May 21 8:20 PM

May 20, 2026

—

Hemab Therapeutics Holdings, Inc.

Purchase

$94.9K

3,802 sh

May 21 8:20 PM

May 19, 2026

—

Hemab Therapeutics Holdings, Inc.

Purchase

$159.0K

6,387 sh

May 14 9:21 PM

May 12, 2026

—

Artiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Purchase

$75.0M

6,510,416 sh

May 13 9:45 PM

May 11, 2026

—

Werewolf Therapeutics, Inc.

Sale

$64.7K

101,151 sh

May 12 10:26 PM

May 12, 2026

—

Werewolf Therapeutics, Inc.

Sale

$58.6K

87,490 sh

May 12 10:26 PM

May 11, 2026

—

Werewolf Therapeutics, Inc.

Sale

$267.3K

376,526 sh

May 12 10:26 PM

May 8, 2026

—

Hemab Therapeutics Holdings, Inc.

Purchase

$989.2K

39,869 sh

May 11 9:44 PM

May 11, 2026

← Previous

Page 1 of 2

Next →